Article

Allergan requests applications to grant program

Allergan Inc. is requesting department chairmen, division chiefs, or fellowship directors of academic institutions to submit grant applications for the Allergan Horizon Grant Program.

Allergan Inc. is requesting department chairmen, division chiefs, or fellowship directors of academic institutions to submit grant applications for the Allergan Horizon Grant Program.

The company plans to contribute $1 million over 2 years to its newly formed Allergan Horizon Grant Program. The program will provide awards to academic medical institutions in order to fund fellowship programs that conduct clinical research in the diagnosis of pharmacologic treatment of glaucoma plus corneal and retinal diseases.

“This program underscores Allergan’s long-term commitment to the ophthalmology community and to the support of research to advance our understanding of ocular disease and improve patient care,” said Steven James, MD, Allergan’s vice president of medical affairs.

Applications must be received by Allergan Medical Affairs by Sept. 30, 2006. Recipients will be announced at the annual meeting of the American Academy of Ophthalmology, Nov. 11-14, 2006, in Las Vegas.

For more information, visit www.allerganhorizongrants.com.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.